Stocktoria

Adaptimmune Therapeutics PLC ADAPY

OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-05-06 · LEI

Adaptimmune Therapeutics PLC statistics & valuation

P / S0.1×
P / B0.8×
Net margin-39.8%
FCF margin-41.6%
Net cash$36.9M
Enterprise value USD-$27.3M
Return on capital-37.9%

Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-223.50% -504.10% -185.40% -160.50% -12225.00% -3286.80% -2571.00% -609.50% -188.90% -39.80% 2015201620172018201920202021202220232024
Gross margin (%)
2015201620172018201920202021202220232024
Operating margin (%)
-249.60% -512.70% -213.20% -138.40% -12457.20% -3370.50% -2638.60% -604.00% -231.80% -38.60% 2015201620172018201920202021202220232024
Return on equity (%)
-8.50% -43.10% -34.60% -38.70% -110.90% -38.10% -76.80% -202.10% -288.20% -597.60% 2015201620172018201920202021202220232024
Shares outstanding
424.7M 424.8M 562.1M 627.5M 631.0M 928.8M 934.8M 987.1M 1.36B 1.54B 2015201620172018201920202021202220232024
Net debt ($)
-$36.9M 2015201620172018201920202021202220232024
Share buybacks ($)
2015201620172018201920202021202220232024
Return on assets (%)
-7.30% -30.50% -24.90% -34.50% -75.60% -28.80% -33.70% -50.30% -40.30% -28.80% 2015201620172018201920202021202220232024
Free cash flow margin (%)
-352.00% -420.30% -208.70% -182.00% -10169.30% -1413.10% 35.00% -630.90% -241.50% -41.60% 2015201620172018201920202021202220232024
Debt / equity (×)
4.58× 2015201620172018201920202021202220232024
EPS ($)
-$0.22 -$0.15 -$0.17 -$0.17 -$0.09 -$0.05 2015201620172018201920202021202220232024

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Operating margin-38.6%-231.8%-604.0%-2638.6%-3370.5%-12457.2%-138.4%-213.2%-512.7%-249.6%
Net margin-39.8%-188.9%-609.5%-2571.0%-3286.8%-12225.0%-160.5%-185.4%-504.1%-223.5%
FCF margin-41.6%-241.5%-630.9%35.0%-1413.1%-10169.3%-182.0%-208.7%-420.3%-352.0%
Return on assets-28.8%-40.3%-50.3%-33.7%-28.8%-75.6%-34.5%-24.9%-30.5%-7.3%
Return on equity-597.6%-288.2%-202.1%-76.8%-38.1%-110.9%-38.7%-34.6%-43.1%-8.5%
Debt / equity4.58×—————————
Current ratio2.922.853.966.6410.193.519.463.104.9411.02

Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.